Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/18/2014 | CN103874698A Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones |
06/18/2014 | CN103874697A Dibenzooxepin derivative |
06/18/2014 | CN103874696A Quinazoline derivatives as kinases inhibitors and methods of use thereof |
06/18/2014 | CN103874695A 2-pyridyloxy-4-nitrile orexin receptor antagonists |
06/18/2014 | CN103874690A Hydrazide containing nuclear transport modulators and uses thereof |
06/18/2014 | CN103874689A Combinations of akt inhibitor compounds and vemurafenib, and methods of use |
06/18/2014 | CN103874687A Benzodioxepin-3-one compounds as dyes or as fluorescent emitters |
06/18/2014 | CN103874686A Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt) |
06/18/2014 | CN103874684A Novel soft rock inhibitors |
06/18/2014 | CN103874683A Novel rock kinase inhibitors |
06/18/2014 | CN103874682A Biphenylcarboxamides as rock kinase inhibitors |
06/18/2014 | CN103874496A 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use |
06/18/2014 | CN103874495A Amino quinazolines as kinase inhibitors |
06/18/2014 | CN103874494A Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k/mtor with bendamustine and/or rituximab |
06/18/2014 | CN103874493A Inhibitors of the renal outer medullary potassium channel |
06/18/2014 | CN103874492A Asymmetric ureas and medical uses thereof |
06/18/2014 | CN103874491A Pentamidine amidoxime acid esters as prodrugs and use thereof as drugs |
06/18/2014 | CN103874490A Combinations of corroles and statins |
06/18/2014 | CN103874489A Compositions comprising salbutamol sulphate |
06/18/2014 | CN103874488A NO- and H2S- releasing compounds |
06/18/2014 | CN103874487A R(+)-N-formyl-propargyl-aminoindan |
06/18/2014 | CN103874486A Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (scnxa) with small molecules |
06/18/2014 | CN103874485A Formulations and dosage forms of oxidized phospholipids |
06/18/2014 | CN103874484A Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin |
06/18/2014 | CN103874480A Sustained release composition of prostacyclin |
06/18/2014 | CN103874427A Probiotic for administration to healthy young mammals during the weaning period for improving tolerance to newly introduced food stuffs |
06/18/2014 | CN103874414A Process and intermediates for preparing macrolactams |
06/18/2014 | CN103874413A 5-fluoro-4-imino-3-(substituted)-3,4-dihydropyrimidin-2-(1H)-ketone derivatives |
06/18/2014 | CN103865967A Branched alpha-glucan, alpha-glucosyltransferase for producing the same, manufacturing method and use therefor |
06/18/2014 | CN103865962A Enzymatic preparation method and application of quercetin-3-O-fatty acid ester |
06/18/2014 | CN103865809A Novel anti-tumor application of penicillium enol B1 from penicillium citrinum |
06/18/2014 | CN103865808A Novel anti-tumor application of penicillium enol A1 from penicillium citrinum |
06/18/2014 | CN103865807A Novel anti-tumor application of penicillium enol B2 from penicillium citrinum |
06/18/2014 | CN103865056A Nonlinear polymer containing doxorubicin structure, and preparation method and application thereof |
06/18/2014 | CN103864962A Amino modified cyclodextrin based artemisinin prodrug and its preparation method |
06/18/2014 | CN103864959A Application of heparin oligosaccharide dp12 in atherosclerosis resistance |
06/18/2014 | CN103864955A Folic acid-glucan conjugate and application thereof |
06/18/2014 | CN103864952A Preparation method and application of micro-molecular glycyrrhiza polysaccharide with anti-tumor activity |
06/18/2014 | CN103864950A Preparation method and application of low-molecular porphyra haitanensis polyferose compound |
06/18/2014 | CN103864947A Process for separating and extracting angelica polysaccharide and application thereof |
06/18/2014 | CN103864946A Porphyra haitanensis polysaccharide positioning sulphating method |
06/18/2014 | CN103864921A Folic acid-adriamycin immunological preparation for treating cancer through dual targets and preparation method thereof |
06/18/2014 | CN103864883A New triterpenoid saponin compound with liver protection effect |
06/18/2014 | CN103864881A Oleanolic acid-uridine conjugate as well as preparation method and application thereof |
06/18/2014 | CN103864874A Phellinus igniarius monomer component ergot ketosteroid and preparation method and application thereof in preparation of anti-tumor drugs |
06/18/2014 | CN103864871A Gemcitabine hydrochloride compound |
06/18/2014 | CN103864851A Ceftobiprole derivatives as prodrug and preparation method and use of ceftobiprole derivatives |
06/18/2014 | CN103864850A Adefovir drug cocrystal with 3,5-dihydroxy-benzoic acid as former and preparation method thereof |
06/18/2014 | CN103864819A Ceftazidime compound and pharmaceutical composition thereof |
06/18/2014 | CN103864816A Thienotetrahydropyridine aromatic acid ether compound as well as preparation method and application thereof |
06/18/2014 | CN103864815A Compound for targeting binding of TFAM (Mitochondrial Transcription Factor A) of mitochondrial DNA (Desoxvribose Nucleic Acid) and application thereof |
06/18/2014 | CN103864811A Novel 10-hydroxy camptothecin site-20 derivative preparation method, and application of 10-hydroxy camptothecin site 20 derivative in anti-tumor drugs |
06/18/2014 | CN103864809A Salt of oxocrebanine derivative |
06/18/2014 | CN103864808A Salts of (-)sukhodianine derivative |
06/18/2014 | CN103864807A Salts of dioxo-dehydrocrebanine derivative |
06/18/2014 | CN103864806A Salts of crebanine derivative |
06/18/2014 | CN103864805A Salts of dehydrocrebanine derivative |
06/18/2014 | CN103864803A Preparation of 1-(phenyl)-1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole derivative and application in antitumor drugs |
06/18/2014 | CN103864797A Compounds with nerve protection function and application thereof |
06/18/2014 | CN103864793A Substituted purin-9-acetamino isohydroxamic acid histone deacetylase inhibitor and preparation method and application thereof |
06/18/2014 | CN103864792A Heterocyclic nitrogen compound acting as tyrosine kinase inhibitor |
06/18/2014 | CN103864791A Entecavir derivative and preparation method thereof |
06/18/2014 | CN103864785A Thiazoline derivatives with aza-indole framework as well as preparation method and application thereof |
06/18/2014 | CN103864784A Novel azaindole-2-ketone FGFR1 (Fibroblast Growth Factor Receptor1) inhibitor and anti-tumor activity thereof |
06/18/2014 | CN103864783A Compounds for the Treatment of Hepatitis C |
06/18/2014 | CN103864781A Novel 1,9-disubstituted tetrahydrocarboline derivative preparation, and application of 1,9-disubstituted tetrahydrocarboline derivatives in anti-tumor drugs |
06/18/2014 | CN103864779A Preparation of 1-(phenyl)-2,3,4,9-tetrahydro-1H-pyridino[3,4-b]indole derivatives and application of derivatives in antitumor drugs |
06/18/2014 | CN103864778A Triethoxy phenanthroquinolizidine salt derivative |
06/18/2014 | CN103864776A Tegafur derivative containing 1,3,4-thiadiazole heterocyclic ring and amide group |
06/18/2014 | CN103864775A 3-methyl-1-[[6-(1H-pyrryl)-2-methylsulfonyl-1-phenyl] benzothiazole]-1H-pyrrole-2-alcohol crystal form and preparation method thereof |
06/18/2014 | CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors |
06/18/2014 | CN103864765A Benzoazepine derivative containing five-membered heterocycle as well as preparation method and application of derivative |
06/18/2014 | CN103864764A Indazole-substituted pyrimidinamine derivative, and preparation method and use thereof |
06/18/2014 | CN103864763A Monohydrate Crystalline Form of 3-(5-(4-(3-Fluoropropyl)-Piperazin-1-YL)Benzimidazol-2-YL)-1-Azaazulen-2-One, Preparation, and Pharmaceutical Composition Thereof |
06/18/2014 | CN103864761A Piperazine derivative containing pyridine as well as preparation method and use of derivative |
06/18/2014 | CN103864760A Hydroxyfasudil compound |
06/18/2014 | CN103864759A Tacrine- nicotinic acid conjugate, preparation method and medical application thereof |
06/18/2014 | CN103864758A Azelnidipine dihydrate, pharmaceutical composition and application of epsilon-crystal-form substance of azelnidipine dihydrate |
06/18/2014 | CN103864757A Preparation method for azelnidipine epsilon-crystal-form substance |
06/18/2014 | CN103864756A Butanedisulfonic acid dabigatran etexilate and preparation method and application thereof |
06/18/2014 | CN103864755A Rabeprazole sodium compound |
06/18/2014 | CN103864754A Five-membered azole heterocycle compound, preparation method, drug composition and use thereof |
06/18/2014 | CN103864751A Gatifloxacin lactate and preparation method thereof |
06/18/2014 | CN103864750A Derivative of N-biphenyl dichloroacetamide as well as preparation method and applications thereof |
06/18/2014 | CN103864749A Duloxetine salt compound and its preparation method |
06/18/2014 | CN103864737A Phenyl C-glucoside derivative containing deoxyglucose structure as well as preparation method and application thereof |
06/18/2014 | CN103864735A Synthesis of novel 5-bromo-3(2H)-benzofuranone derivatives and application in antitumor drugs |
06/18/2014 | CN103864734A Synthesis and application of novel 4,6-dihydroxy-3(2H)-benzofuranone derivatives |
06/18/2014 | CN103864721A Repaglinide compound |
06/18/2014 | CN103864720A Phenyl acrylic acid farnesyl thiosalicylic acid (FTA) derivative as well as preparation method and application |
06/18/2014 | CN103864699A Preparation and application of new non-nucleoside S-DABOs pyrimidone derivatives having both anti-HBV effect and anti-HIV and anti-HCV effects |
06/18/2014 | CN103864690A S crystal form of ivabradine hydrochloride, and preparation method and pharmaceutical composition thereof |
06/18/2014 | CN103864688A Salt of oxodehydrocaaverine derivative |
06/18/2014 | CN103864687A Dicranostigma leptopodum berberrubine salt derivative |
06/18/2014 | CN103864684A Synthesis of novel 3,4-dihydro-1(2H)isoquinoline derivatives and application in antitumor drugs |
06/18/2014 | CN103864681A Antibacterial chloroxoquinoline derivative |
06/18/2014 | CN103864680A Chloroxoquinoline derivatives with anti-tumor activity |
06/18/2014 | CN103864669A Novel crystal form of Mitiglinide calcium and preparation method thereof |
06/18/2014 | CN103864664A Bazedoxifene acetate new crystal form and preparation method thereof |
06/18/2014 | CN103864658A Azacyclobutanone derivatives as well as preparation method and application thereof |